Coldstream Capital Management Inc Eli Lilly & CO Transaction History

Coldstream Capital Management Inc

$4.58 Billion
Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Coldstream Capital Management Inc holds 23,189 shares of LLY stock, worth $18.1 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

23,189

Previous 23,732 2.29%

Holding current value

$18.1 Million

Previous $21.5 Million 4.38%

% of portfolio

0.45%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$772.14 - $960.02 $419,272 - $521,290	-543 Reduced 2.29%	23,189 $20.5 Million
Q2 2024 Aug 07, 2024	SELL	$724.87 - $909.04 $27,545 - $34,543	-38 Reduced 0.16%	23,732 $21.5 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $133,245 - $178,263	225 Added 0.96%	23,770 $18.5 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $49,367 - $58,198	94 Added 0.4%	23,545 $13.7 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $3.6 Million - $4.96 Million	8,279 Added 54.57%	23,451 $12.6 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $114,341 - $152,887	326 Added 2.2%	15,172 $7.12 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $76,725 - $90,110	247 Added 1.69%	14,846 $5.1 Million
Q4 2022 Jan 10, 2023	BUY	$321.55 - $374.67 $154,987 - $180,590	482 Added 3.41%	14,599 $0
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $1.44 Million - $1.69 Million	5,177 Added 57.91%	14,117 $4.58 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $914,791 - $1.07 Million	-3,282 Reduced 26.85%	8,940 $2.9 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $272,005 - $338,033	-1,159 Reduced 8.66%	12,222 $3.5 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.23 Million - $1.53 Million	5,477 Added 69.29%	13,381 $3.7 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $34,126 - $41,997	-154 Reduced 1.91%	7,904 $1.17 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $16,249 - $21,018	90 Added 1.13%	8,058 $1.85 Million
Q1 2021 Jun 16, 2021	SELL	$164.32 - $212.72 $12,159 - $15,741	-74 Reduced 0.92%	7,968 $1.49 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $94,061 - $124,466	721 Added 9.85%	8,042 $1.36 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $40,356 - $46,679	-276 Reduced 3.63%	7,321 $1.08 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $355,783 - $428,181	2,608 Added 52.28%	7,597 $1.25 Million
Q1 2020 May 27, 2020	BUY	$119.05 - $147.35 $44,881 - $55,550	377 Added 8.17%	4,989 $692,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $4,704 - $5,826	-44 Reduced 0.95%	4,612 $606,000
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $30,755 - $33,454	-288 Reduced 5.83%	4,656 $521,000
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $14,735 - $17,199	-133 Reduced 2.62%	4,944 $548,000
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $18,922 - $22,273	-170 Reduced 3.24%	5,077 $659,000
Q4 2018 Feb 26, 2019	BUY	$105.9 - $118.64 $123,373 - $138,215	1,165 Added 28.54%	5,247 $607,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $26,702 - $33,373	311 Added 8.25%	4,082 $438,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $60,181 - $69,069	795 Added 26.71%	3,771 $322,000
Q1 2018 May 16, 2018	SELL	$74.21 - $87.6 $34,210 - $40,383	-461 Reduced 13.41%	2,976 $230,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $53,670 - $57,567	655 Added 23.54%	3,437 $290,000
Q3 2017 Nov 15, 2017	SELL	$77.07 - $85.54 $11,175 - $12,403	-145 Reduced 4.95%	2,782 $238,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,927	2,927 $241,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Eli Lilly & CO Transaction History